Ahnfelt-Rønne I, Bramm E, Arrigoni-Martelli E
Agents Actions. 1981 Dec;11(6-7):587-9. doi: 10.1007/BF01978753.
The development of chronic inflammation in adjuvant arthritic rats was found to be strongly correlated with the appearance in serum of a factor (HSF) which enhanced the formation of 12-L-HETE by platelet-lipoxygenase, and with the serum-concentration of 12-L-HETE. The latter was determined by scanning at 235 nm after extraction and high performance thin-layer chromatography. Arthritic rat platelet-rich plasma (PRP) converted exogenous arachidonic acid to 12-L-HETE at a rate 2.6-fold higher than control rat PRP. By resuspending arthritic rat platelets in normal rat plasma, and normal rat platelets in arthritic rat plasma, this increase in conversion rate was found to be caused by HSF present in the arthritic rat plasma. Treatment of arthritis with non-steroidal anti-inflammatory drugs inhibited HSF activity as well as the increase in serum-12-L-HETE concentration, which indicates a prostaglandin-mediated mechanism of HSF synthesis or release.
研究发现,佐剂性关节炎大鼠慢性炎症的发展与血清中一种因子(HSF)的出现密切相关,该因子可增强血小板脂氧合酶形成12-L-HETE的能力,且与血清中12-L-HETE的浓度相关。后者是在提取和高效薄层色谱后于235nm处扫描测定的。关节炎大鼠富含血小板血浆(PRP)将外源性花生四烯酸转化为12-L-HETE的速率比对照大鼠PRP高2.6倍。通过将关节炎大鼠血小板重悬于正常大鼠血浆中,以及将正常大鼠血小板重悬于关节炎大鼠血浆中,发现转化率的这种增加是由关节炎大鼠血浆中存在的HSF引起的。用非甾体抗炎药治疗关节炎可抑制HSF活性以及血清12-L-HETE浓度的升高,这表明HSF合成或释放存在前列腺素介导的机制。